Mar 28 |
Lyra Therapeutics (LYRA) Soars 6.5%: Is Further Upside Left in the Stock?
|
Mar 21 |
Alpine Immune Sciences Presents New Translational Data on Povetacicept at the European Lupus Meeting 2024
|
Mar 20 |
Alpine Immune Sciences to Participate in Upcoming H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
|
Mar 20 |
Here's Why We're Not Too Worried About Alpine Immune Sciences' (NASDAQ:ALPN) Cash Burn Situation
|
Mar 19 |
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Q4 2023 Earnings Call Transcript
|
Mar 19 |
Q4 2023 Alpine Immune Sciences Inc Earnings Call
|
Mar 18 |
Alpine Immune Sciences, Inc. (ALPN) Q4 Earnings and Revenues Beat Estimates
|
Mar 18 |
Alpine Immune Sciences, Inc. (ALPN) Q4 2023 Earnings Call Transcript
|
Mar 18 |
Alpine Immune Sciences Inc (ALPN) Reports Full Year 2023 Financial Results
|
Mar 18 |
Alpine Immune Sciences GAAP EPS of -$0.64, revenue of $58.88M
|